X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.indianpharmapost.com/drug-approval/sun-pharmaceuticals-receives-approval-for-winlevi-in-australia-15416
https://www.indianpharmapost.com/news/sun-pharma-canada-launches-prwinlevi-for-treatment-for-acne-14721
https://www.biospectrumasia.com/news/25/21678/hyphens-pharma-licenses-winlevi-for-acne-improvement-in-10-countries-across-southeast-asia.html
https://www.prnewswire.com/news-releases/sun-pharma-presents-phase-3-data-for-winlevi-clascoterone-cream-1-for-the-topical-treatment-of-acne-vulgaris-at-the-aad-annual-meeting-301510376.html
https://sunpharma.com/wp-content/uploads/2021/11/Press-Release-Winlevi-availability-in-US.pdf
https://www.cosmopharma.com/news-and-media/news-releases/2021/210726
https://www.cosmopharma.com/news-and-media/news-releases/2021/210726
https://www.businesswire.com/news/home/20201030005028/en/Albany-Molecular-Research-Inc.-AMRI-Named-Exclusive-API-Supplier-for-Recently-Approved-Acne-Treatment
https://www.reuters.com/article/us-cassiopea-winlevi/cassiopea-gets-u-s-fda-approval-for-acne-treatment-winlevi-idUSKBN25N0H6
Market Place
Share 
